UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending June 30, 2025, UroGen Pharma generated $24.21M in revenue.
Revenue (ttm)
90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
386.32K
Employees
234
Market Cap
913.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|